Hungarian Centre of Excellence for Molecular Medicine

Strong catalyst of reformative changes in biomedical science and in institutional research management

News

We are happy to announce the Joint semi-online Summer School in Molecular Medicine organised by Semmelweis University and HCEMM, which will take place from 5 to 7 October 2020.

The Summer School runs over a two and a half day period and comprises of different short lectures on Technology Transfer, Innovative R&D in practice, Early phase health technology assessment and Design thinking.

Our main target group is PhD students of HCEMM Research Groups and medical PhD students.

If you want to take the opportunity and enjoy high quality, free courses on these topics, we invite you to save the date, and apply for this practical course.

Please find more information on the following link, and apply through the webpage. The deadline for application is 25 September, 2020.

https://www.hcemm.eu/pub/HCEMM_SummerSchool_Promo.pdf

Details for Summer School 2020 will be updated in the beginning of October, 2020.

Who we are

The Hungarian Centre of Excellence for Molecular Medicine – HCEMM – is a game changer organization which catalyzes reforming changes in the research culture and makes impact in the regional development of Hungarian knowledge regions.
The organizational and management model ensures autonomy and scientific excellence with an international evaluation system. Research groups are pursuing in cross cutting fields and are reviewed every 5 years in order to ensure scientific excellence. HCEMM focuses on and supports molecular medicine-oriented research activities targeting key, highly prevalent ageing-related non-communicable diseases.

HCEMM was created by the union of the University of Szeged, the Semmelweis University and the Biological Research Centre. They were joined by the National Research, Innovation and Development Office representing the Hungarian Government as project coordinator and by the European Molecular Biology Laboratory (EMBL) as advanced scientific institution.

Supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

Research Strategy

HCEMM focuses on and supports molecular medicine-oriented research activities targeting key, highly prevalent ageing-related non-communicable diseases.

In Partnership with

Consortium Partners

This website uses cookies. For more information visit the Cookies & Privacy Policy page.